Analysis of Factors That May Affect the Effect of Atropine 0.01% on Myopia Control
Children respond differently to atropine treatment, and predicting patient factors associated with better myopia control is important. Therefore, we aimed to evaluate factors related to myopia progression in Chinese children treated with atropine 0.01%. This retrospective study included 133 children...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-09-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2020.01081/full |
id |
doaj-1ceb8a538c7a4efda2ed29e8d74cb72b |
---|---|
record_format |
Article |
spelling |
doaj-1ceb8a538c7a4efda2ed29e8d74cb72b2020-11-25T02:52:41ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122020-09-011110.3389/fphar.2020.01081542496Analysis of Factors That May Affect the Effect of Atropine 0.01% on Myopia ControlXiaoyu Zhang0Xiaoyu Zhang1Xiaoyu Zhang2Yuliang Wang3Yuliang Wang4Yuliang Wang5Xingtao Zhou6Xingtao Zhou7Xingtao Zhou8Xiaomei Qu9Xiaomei Qu10Xiaomei Qu11Key NHC Key Laboratory of Myopia (Fudan University), Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, ChinaDepartment of Ophthalmology, The Eye and ENT Hospital of Fudan University, Shanghai, ChinaShanghai Research Center of Ophthalmology and Optometry, Shanghai, ChinaKey NHC Key Laboratory of Myopia (Fudan University), Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, ChinaDepartment of Ophthalmology, The Eye and ENT Hospital of Fudan University, Shanghai, ChinaShanghai Research Center of Ophthalmology and Optometry, Shanghai, ChinaKey NHC Key Laboratory of Myopia (Fudan University), Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, ChinaDepartment of Ophthalmology, The Eye and ENT Hospital of Fudan University, Shanghai, ChinaShanghai Research Center of Ophthalmology and Optometry, Shanghai, ChinaKey NHC Key Laboratory of Myopia (Fudan University), Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, ChinaDepartment of Ophthalmology, The Eye and ENT Hospital of Fudan University, Shanghai, ChinaShanghai Research Center of Ophthalmology and Optometry, Shanghai, ChinaChildren respond differently to atropine treatment, and predicting patient factors associated with better myopia control is important. Therefore, we aimed to evaluate factors related to myopia progression in Chinese children treated with atropine 0.01%. This retrospective study included 133 children who were administered atropine 0.01% eyedrops every night for 1 year. Enrolled children were examined at follow-up visits at 3 and 6 months, and 1 year. The primary outcome was clinically significant myopia progression (over a -0.75 diopter (D) increase in spherical equivalent (SE)). Multivariate logistic analysis was used to identify predictive factors for myopia progression. The mean baseline SE was -3.92 ± 2.76D, and the average increase in SE and axial length at 1 year from baseline were -0.55 ± 0.57D and 0.43 ± 0.52 mm, respectively. The risk of myopia progression significantly increased in children whose mothers had moderate myopia of less than -6D compared to that in children whose mothers had no history of myopia (odd ratio [OR] = 2.76, 95% confidence interval [CI]: 1.06 to 7.19, P = 0.0382). Birth by cesarean section was also a risk factor for myopia progression (odd ratio [OR] = 2.35, 95% CI: 1.30 to 4.27, P = 0.0048). The correlation between SE and treatment efficiency was linear, and the risk of myopia progression significantly decreased with increasing SE. Atropine 0.01% controlled myopia more effectively in children with higher myopia, who were delivered naturally, and whose mothers had no genetic background of myopia.https://www.frontiersin.org/article/10.3389/fphar.2020.01081/fullmyopiaatropineretrospective studyChinese childrenmyopia progression |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Xiaoyu Zhang Xiaoyu Zhang Xiaoyu Zhang Yuliang Wang Yuliang Wang Yuliang Wang Xingtao Zhou Xingtao Zhou Xingtao Zhou Xiaomei Qu Xiaomei Qu Xiaomei Qu |
spellingShingle |
Xiaoyu Zhang Xiaoyu Zhang Xiaoyu Zhang Yuliang Wang Yuliang Wang Yuliang Wang Xingtao Zhou Xingtao Zhou Xingtao Zhou Xiaomei Qu Xiaomei Qu Xiaomei Qu Analysis of Factors That May Affect the Effect of Atropine 0.01% on Myopia Control Frontiers in Pharmacology myopia atropine retrospective study Chinese children myopia progression |
author_facet |
Xiaoyu Zhang Xiaoyu Zhang Xiaoyu Zhang Yuliang Wang Yuliang Wang Yuliang Wang Xingtao Zhou Xingtao Zhou Xingtao Zhou Xiaomei Qu Xiaomei Qu Xiaomei Qu |
author_sort |
Xiaoyu Zhang |
title |
Analysis of Factors That May Affect the Effect of Atropine 0.01% on Myopia Control |
title_short |
Analysis of Factors That May Affect the Effect of Atropine 0.01% on Myopia Control |
title_full |
Analysis of Factors That May Affect the Effect of Atropine 0.01% on Myopia Control |
title_fullStr |
Analysis of Factors That May Affect the Effect of Atropine 0.01% on Myopia Control |
title_full_unstemmed |
Analysis of Factors That May Affect the Effect of Atropine 0.01% on Myopia Control |
title_sort |
analysis of factors that may affect the effect of atropine 0.01% on myopia control |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Pharmacology |
issn |
1663-9812 |
publishDate |
2020-09-01 |
description |
Children respond differently to atropine treatment, and predicting patient factors associated with better myopia control is important. Therefore, we aimed to evaluate factors related to myopia progression in Chinese children treated with atropine 0.01%. This retrospective study included 133 children who were administered atropine 0.01% eyedrops every night for 1 year. Enrolled children were examined at follow-up visits at 3 and 6 months, and 1 year. The primary outcome was clinically significant myopia progression (over a -0.75 diopter (D) increase in spherical equivalent (SE)). Multivariate logistic analysis was used to identify predictive factors for myopia progression. The mean baseline SE was -3.92 ± 2.76D, and the average increase in SE and axial length at 1 year from baseline were -0.55 ± 0.57D and 0.43 ± 0.52 mm, respectively. The risk of myopia progression significantly increased in children whose mothers had moderate myopia of less than -6D compared to that in children whose mothers had no history of myopia (odd ratio [OR] = 2.76, 95% confidence interval [CI]: 1.06 to 7.19, P = 0.0382). Birth by cesarean section was also a risk factor for myopia progression (odd ratio [OR] = 2.35, 95% CI: 1.30 to 4.27, P = 0.0048). The correlation between SE and treatment efficiency was linear, and the risk of myopia progression significantly decreased with increasing SE. Atropine 0.01% controlled myopia more effectively in children with higher myopia, who were delivered naturally, and whose mothers had no genetic background of myopia. |
topic |
myopia atropine retrospective study Chinese children myopia progression |
url |
https://www.frontiersin.org/article/10.3389/fphar.2020.01081/full |
work_keys_str_mv |
AT xiaoyuzhang analysisoffactorsthatmayaffecttheeffectofatropine001onmyopiacontrol AT xiaoyuzhang analysisoffactorsthatmayaffecttheeffectofatropine001onmyopiacontrol AT xiaoyuzhang analysisoffactorsthatmayaffecttheeffectofatropine001onmyopiacontrol AT yuliangwang analysisoffactorsthatmayaffecttheeffectofatropine001onmyopiacontrol AT yuliangwang analysisoffactorsthatmayaffecttheeffectofatropine001onmyopiacontrol AT yuliangwang analysisoffactorsthatmayaffecttheeffectofatropine001onmyopiacontrol AT xingtaozhou analysisoffactorsthatmayaffecttheeffectofatropine001onmyopiacontrol AT xingtaozhou analysisoffactorsthatmayaffecttheeffectofatropine001onmyopiacontrol AT xingtaozhou analysisoffactorsthatmayaffecttheeffectofatropine001onmyopiacontrol AT xiaomeiqu analysisoffactorsthatmayaffecttheeffectofatropine001onmyopiacontrol AT xiaomeiqu analysisoffactorsthatmayaffecttheeffectofatropine001onmyopiacontrol AT xiaomeiqu analysisoffactorsthatmayaffecttheeffectofatropine001onmyopiacontrol |
_version_ |
1724728274017320960 |